FUND+
Fund+ is a venture capital firm that invests in companies operating in the diagnostics, therapeutics, medical devices, and life science sectors. The firm wants to create sustainable shareholders' value, contribute to the development of a leadership position in the life sciences sector, and generate a tangible, beneficial societal impact. Fund+ was established in 2015 and is based in Leuven, Belgium.
FUND+
Founded:
2015-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Nginx
Similar Organizations
1315 Capital
1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Susquehanna Growth Equity
Susquehanna Growth Equity invests in growth stage technology companies in the software, information services, and internet.
Winton Ventures
Winton Ventures invests in companies operating in the cybersecurity; energy and environment; and data science-driven healthcare sectors.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-25 | AstriVax | Fund+ investment in Seed Round - AstriVax | 30 M EUR |
| 2022-08-23 | eTheRNA immunotherapies | Fund+ investment in Series B - eTheRNA immunotherapies | 39 M EUR |
| 2022-05-31 | Minoryx Therapeutics | Fund+ investment in Series C - Minoryx Therapeutics | 51 M EUR |
| 2022-05-03 | Tubulis | Fund+ investment in Series B - Tubulis | 60 M EUR |
| 2022-02-19 | TargED Biopharmaceuticals | Fund+ investment in Series A - TargED Biopharmaceuticals | 39 M EUR |
| 2021-12-24 | EyeD Pharma | Fund+ investment in Venture Round - EyeD Pharma | 45 M EUR |
| 2021-10-28 | Novadip Biosciences | Fund+ investment in Series B - Novadip Biosciences | 19 M EUR |
| 2021-10-22 | Egle Therapeutics | Fund+ investment in Series A - Egle Therapeutics | 40 M EUR |
| 2021-08-25 | Cardior Pharmaceuticals | Fund+ investment in Series B - Cardior Pharmaceuticals | 64 M EUR |
| 2020-07-28 | ExeVir Bio | Fund+ investment in Series A - ExeVir Bio | 42 M EUR |